Compound information
- Natural Products
- ZC550935
- Molecular Formula
- C17H26N2O6S
- Molecular Weight
- 386.151157552 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(3,4-dimethoxyphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H26N2O6S/c1-17(2,3)25-16(20)18-8-10-19(11-9-18)26(21,22)13-6-7-14(23-4)15(12-13)24-5/h6-7,12H,8-11H2,1-5H3
- InChI Key
- PIKFROOENOPSCA-UHFFFAOYSA-N
- SMILES
- COc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1OC
- Source
- ZINC000017078866
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 85.38 Å2 | LogP | 2.127 |
LogS | -2.988 | LogD | 3.044 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.049 | Pgp substrate | 0.02 |
HIA | 0.969 | F20 % | 0.958 |
F30 % | 0.909 | Caco-2 | -4.46 |
MDCK | -4.923 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.942 | PPB | 93.092 |
VD | 1.744 | Fu | 0.472 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.055 | CYP1A2 substrate | 0.462 |
CYP2A6 substrate | 0.519 | CYP2B6 substrate | 0.584 |
CYP2C19 inhibitor | 0.822 | CYP2C19 substrate | 0.64 |
CYP2C8 substrate | 0.654 | CYP2C9 inhibitor | 0.05 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.002 |
CYP2D6 substrate | 0.662 | CYP2E1 substrate | 0.89 |
CYP3A4 inhibitor | 0.29 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.656 | CL | 5.722 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.799 | Hepatotoxicity | 0.973 |
Mutagenicity | 0.026 | Rat Oral Acute Toxicity | 0.187 |
FDAMDD | 0.031 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.908 | Eye Corrosion | 0.005 |
Eye Irritation | 0.006 | Respiratory Toxicity | 0.725 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.483 | IGC50 | 2.825 |
LC50FM | 2.375 | LC50DM | 2.101 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.501 | NR-AR-LBD | 0.243 |
NR-AhR | 0.04 | NR-Aromatase | 0.09 |
NR-ER | 0.295 | NR-ER-LBD | 0.385 |
NR-PPAR-gamma | 0.099 | SR-ARE | 0.691 |
SR-ATAD5 | 0.393 | SR-HSE | 0.047 |
SR-MMP | 0.028 | SR-p53 | 0.028 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.